Loading…

Cospray Dried Antibiotics for Dry Powder Lung Delivery

The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 2008-08, Vol.97 (8), p.3356-3366
Main Authors: Adi, Handoko, Young, Paul M., Chan, Hak-Kim, Stewart, Peter, Agus, Helen, Traini, Daniela
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053
cites cdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053
container_end_page 3366
container_issue 8
container_start_page 3356
container_title Journal of pharmaceutical sciences
container_volume 97
creator Adi, Handoko
Young, Paul M.
Chan, Hak-Kim
Stewart, Peter
Agus, Helen
Traini, Daniela
description The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.
doi_str_mv 10.1002/jps.21239
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69358508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916326375</els_id><sourcerecordid>69358508</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</originalsourceid><addsrcrecordid>eNp10E1P2zAYB3BrAo3S7cAXQLkMiUOKHdtxfISWFlC1VXvRjpZrP5nM0qTYaUu-PYZ0cBknS_bvefEfoROCRwTj7OJ-HUYZyaj8gAaEZzjNMREHaBDfspRyJo_QcQj3GOMcc_4RHREhJaaYD1A-bsLa6y6ZeAc2uaxbt3RN60xIysbH2y5ZNDsLPplv6j_JBCq3Bd99QoelrgJ83p9D9Gt6_XN8k86_zW7Hl_PUMMplmhtJdckKxgAkg1ywJZWMFWA5J6bg0hQ5IVxwJorSFlIyQYwsgVhm-RJzOkRnfd-1bx42EFq1csFAVekamk1QuaS84LiI8LyHxjcheCjV2ruV9p0iWD2HpGJI6iWkaE_3TTfLFdg3uU8lgi97oIPRVel1bVx4dRmO-xJBo7vo3c5V0L0_Ud0tfvwbnfYVLrTw-Fqh_V-VCyq4-v119lw8_06upmoSPe09xJC3DrwKxkFtwDoPplW2cf_54BNdwJvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69358508</pqid></control><display><type>article</type><title>Cospray Dried Antibiotics for Dry Powder Lung Delivery</title><source>ScienceDirect (Online service)</source><source>Wiley Online Library All Journals</source><creator>Adi, Handoko ; Young, Paul M. ; Chan, Hak-Kim ; Stewart, Peter ; Agus, Helen ; Traini, Daniela</creator><creatorcontrib>Adi, Handoko ; Young, Paul M. ; Chan, Hak-Kim ; Stewart, Peter ; Agus, Helen ; Traini, Daniela</creatorcontrib><description>The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.21239</identifier><identifier>PMID: 17990305</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>Administration, Inhalation ; Aerosols ; Anti-Bacterial Agents - administration &amp; dosage ; antibiotics ; Biological and medical sciences ; Ciprofloxacin - administration &amp; dosage ; ciprofloxacin hydrochloride ; cospray drying ; Doxycycline - administration &amp; dosage ; doxycycline hydrochloride ; DPI ; Drug Combinations ; dry powder inhaler ; General pharmacology ; Humans ; Lung - metabolism ; Medical sciences ; Microbial Sensitivity Tests ; Microscopy, Electron, Scanning ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Powders ; Pseudomonas aeruginosa - drug effects ; Staphylococcus aureus - drug effects ; Streptococcus pyogenes - drug effects ; X-Ray Diffraction</subject><ispartof>Journal of pharmaceutical sciences, 2008-08, Vol.97 (8), p.3356-3366</ispartof><rights>2008 Wiley‐Liss, Inc.</rights><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</citedby><cites>FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.21239$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022354916326375$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,1417,3549,27924,27925,45574,45575,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20547173$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17990305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adi, Handoko</creatorcontrib><creatorcontrib>Young, Paul M.</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><creatorcontrib>Stewart, Peter</creatorcontrib><creatorcontrib>Agus, Helen</creatorcontrib><creatorcontrib>Traini, Daniela</creatorcontrib><title>Cospray Dried Antibiotics for Dry Powder Lung Delivery</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.</description><subject>Administration, Inhalation</subject><subject>Aerosols</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>antibiotics</subject><subject>Biological and medical sciences</subject><subject>Ciprofloxacin - administration &amp; dosage</subject><subject>ciprofloxacin hydrochloride</subject><subject>cospray drying</subject><subject>Doxycycline - administration &amp; dosage</subject><subject>doxycycline hydrochloride</subject><subject>DPI</subject><subject>Drug Combinations</subject><subject>dry powder inhaler</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Lung - metabolism</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microscopy, Electron, Scanning</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Powders</subject><subject>Pseudomonas aeruginosa - drug effects</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Streptococcus pyogenes - drug effects</subject><subject>X-Ray Diffraction</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp10E1P2zAYB3BrAo3S7cAXQLkMiUOKHdtxfISWFlC1VXvRjpZrP5nM0qTYaUu-PYZ0cBknS_bvefEfoROCRwTj7OJ-HUYZyaj8gAaEZzjNMREHaBDfspRyJo_QcQj3GOMcc_4RHREhJaaYD1A-bsLa6y6ZeAc2uaxbt3RN60xIysbH2y5ZNDsLPplv6j_JBCq3Bd99QoelrgJ83p9D9Gt6_XN8k86_zW7Hl_PUMMplmhtJdckKxgAkg1ywJZWMFWA5J6bg0hQ5IVxwJorSFlIyQYwsgVhm-RJzOkRnfd-1bx42EFq1csFAVekamk1QuaS84LiI8LyHxjcheCjV2ruV9p0iWD2HpGJI6iWkaE_3TTfLFdg3uU8lgi97oIPRVel1bVx4dRmO-xJBo7vo3c5V0L0_Ud0tfvwbnfYVLrTw-Fqh_V-VCyq4-v119lw8_06upmoSPe09xJC3DrwKxkFtwDoPplW2cf_54BNdwJvc</recordid><startdate>200808</startdate><enddate>200808</enddate><creator>Adi, Handoko</creator><creator>Young, Paul M.</creator><creator>Chan, Hak-Kim</creator><creator>Stewart, Peter</creator><creator>Agus, Helen</creator><creator>Traini, Daniela</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200808</creationdate><title>Cospray Dried Antibiotics for Dry Powder Lung Delivery</title><author>Adi, Handoko ; Young, Paul M. ; Chan, Hak-Kim ; Stewart, Peter ; Agus, Helen ; Traini, Daniela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Administration, Inhalation</topic><topic>Aerosols</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>antibiotics</topic><topic>Biological and medical sciences</topic><topic>Ciprofloxacin - administration &amp; dosage</topic><topic>ciprofloxacin hydrochloride</topic><topic>cospray drying</topic><topic>Doxycycline - administration &amp; dosage</topic><topic>doxycycline hydrochloride</topic><topic>DPI</topic><topic>Drug Combinations</topic><topic>dry powder inhaler</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Lung - metabolism</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microscopy, Electron, Scanning</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Powders</topic><topic>Pseudomonas aeruginosa - drug effects</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Streptococcus pyogenes - drug effects</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adi, Handoko</creatorcontrib><creatorcontrib>Young, Paul M.</creatorcontrib><creatorcontrib>Chan, Hak-Kim</creatorcontrib><creatorcontrib>Stewart, Peter</creatorcontrib><creatorcontrib>Agus, Helen</creatorcontrib><creatorcontrib>Traini, Daniela</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adi, Handoko</au><au>Young, Paul M.</au><au>Chan, Hak-Kim</au><au>Stewart, Peter</au><au>Agus, Helen</au><au>Traini, Daniela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cospray Dried Antibiotics for Dry Powder Lung Delivery</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2008-08</date><risdate>2008</risdate><volume>97</volume><issue>8</issue><spage>3356</spage><epage>3366</epage><pages>3356-3366</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>The aim of this study was to assess the potential of delivering a combination antibiotic therapy, containing doxycycline and ciprofloxacin (both hydrochloride) as a dry powder (DPI) formulation for inhalation. Single and combination antibiotics were produced by spray drying. Particle size distributions were characterized by laser diffraction and imaging conducted by scanning electron microscopy. Solid-state characterisation of the antibiotics was carried out using differential scanning calorimetry, dynamic vapour sorption, X-ray powder diffraction, and differential scanning calorimetry. Using the Aerolizer® device, the aerosol performance was measured using multistage liquid impinger and analysed using high performance liquid chromatography (R2 = 1.0, CV = 0.4–1.0%). Furthermore, a disk diffusion test was performed for the assessment of the in vitro antimicrobial activity of the raw and spray dried antibiotics against bacteria. Results showed that cospray drying of the ciprofloxacin and doxycycline produced an antibiotic formulation (in a 1:1 ratio) suitable for inhalation that showed to be physically more stable then the analogous single spray dried antibiotic. The cospray dried powder has improved dispersion over the less stable single spray dried ciprofloxacin. The spray dried antibiotics were observed to have similar antimicrobial activity to the original antibiotics for Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyrogenes, suggesting the spray drying process does not affect the anti-bacterial activity of the drug. Cospray dried antibiotics from a DPI is thus feasible and can potentially be an attractive delivery alternative to the more conventional systemic delivery route.</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>17990305</pmid><doi>10.1002/jps.21239</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2008-08, Vol.97 (8), p.3356-3366
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_69358508
source ScienceDirect (Online service); Wiley Online Library All Journals
subjects Administration, Inhalation
Aerosols
Anti-Bacterial Agents - administration & dosage
antibiotics
Biological and medical sciences
Ciprofloxacin - administration & dosage
ciprofloxacin hydrochloride
cospray drying
Doxycycline - administration & dosage
doxycycline hydrochloride
DPI
Drug Combinations
dry powder inhaler
General pharmacology
Humans
Lung - metabolism
Medical sciences
Microbial Sensitivity Tests
Microscopy, Electron, Scanning
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Powders
Pseudomonas aeruginosa - drug effects
Staphylococcus aureus - drug effects
Streptococcus pyogenes - drug effects
X-Ray Diffraction
title Cospray Dried Antibiotics for Dry Powder Lung Delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A08%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cospray%20Dried%20Antibiotics%20for%20Dry%20Powder%20Lung%20Delivery&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Adi,%20Handoko&rft.date=2008-08&rft.volume=97&rft.issue=8&rft.spage=3356&rft.epage=3366&rft.pages=3356-3366&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.21239&rft_dat=%3Cproquest_cross%3E69358508%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4359-6c93af4844ee94e674b39448ed551c859c8611575478fd899471c9fe1d4d5b053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69358508&rft_id=info:pmid/17990305&rfr_iscdi=true